300562 logo

Guangdong Transtek Medical Electronics
300562

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥2.89B
EV
CN¥2.26B
Shares Outstanding
216.88M
Beta
-0.02
Industry
Medical - Devices

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2025E
-
P/Revenue 2025E
-

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
-
Net Profit Margin 2025E
-
ROE 2025E
-
ROCE 2024
6.03%

Dividends

DPS 2025E
-
Payout Ratio 2025E
-
Div. Yield 2025E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Guangdong Transtek Medical Electronics Co., Ltd

gainify
300562 logo

Guangdong Transtek Medical Electronics Co., Ltd

300562

Guangdong Transtek Medical Electronics Co., Ltd provides smart wearables and mobile medical care products in China and internationally. The company offers wearable sports bracelets and watches, electronic health scales, fat measuring instruments, electronic blood pres...

Sector

Healthcare

Industry

Medical - Devices

CEO

Pan, Wei Chao

Employees

1,182

IPO Date

2016-11-16

Headquarters

Torch Development Zone, No.105 Dongli Road, National Health Technology Industrial Base, Zhongshan, Guangdong Province, 528437, China

📊 Stock Price & Performance

The last closing price of Guangdong Transtek Medical Electronics (300562) is CN¥13.33, reflecting a -0.82% change from the prior session. Last updated: January 1, 2026 at 2:03 AM Eastern Time

Review the recent 300562 stock performance trends:Past 1 Month: Guangdong Transtek Medical Electronics (300562) shares have -6.13%.Past 3 Months: The stock has -5.99%.Past 6 Months: 300562 shares have -9.63%. Last updated: January 1, 2026 at 12:06 AM Eastern Time

Over the last year, Guangdong Transtek Medical Electronics (300562) has established a 52-week price range between a high of CN¥19.10 and a low of CN¥11.00. This metric is essential for assessing the stock's annual volatility. Last updated: January 1, 2026 at 12:06 AM Eastern Time

Guangdong Transtek Medical Electronics (300562) is considered a low volatility stock. It has a beta of -0.02, which means it typically moves in the opposite direction of the broader market, with a magnitude of approximately 0.02 times the market's movement. Over the past 52 weeks, 300562 has traded within a CN¥11.00 – CN¥19.10 range. Last updated: January 1, 2026 at 12:06 AM Eastern Time

A CN¥1,000 investment in Guangdong Transtek Medical Electronics 5 years ago, when the stock was trading around CN¥21.89, would be worth approximately CN¥609.09 today, based solely on share price performance (excluding dividends). This represents a total return of -39.09% over the period, equivalent to a compound annual growth rate (CAGR) of -9.44%. Past performance reflects historical price movements only and does not imply future results. Last updated: January 1, 2026 at 12:06 AM Eastern Time

💰 Financial Metrics & Reports

The current Guangdong Transtek Medical Electronics (300562) market capitalization is approximately CN¥2.89B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Guangdong Transtek Medical Electronics's market cap fluctuates with changes in its share price and share count. Last updated: January 1, 2026 at 12:06 AM Eastern Time

In the most recently reported quarter, Guangdong Transtek Medical Electronics (300562) generated CN¥235.76M in revenue, representing a -8.53% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 3:44 AM Eastern Time

In the most recently reported fiscal year, Guangdong Transtek Medical Electronics (300562) generated net income of CN¥61.36M, compared with CN¥34.37M in the prior fiscal year, representing a +78.55% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 3:44 AM Eastern Time

According to its latest quarterly filing, Guangdong Transtek Medical Electronics (300562) reported EBITDA of CN¥32.45M, representing a +21.57% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 3:44 AM Eastern Time

As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.10x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 3:44 AM Eastern Time

Based on the latest available data, Guangdong Transtek Medical Electronics (300562) is currently trading at a last twelve months (LTM) P/E ratio of 37.78x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 3:44 AM Eastern Time

📅 Earnings & Dividends

In the most recently reported quarter, Guangdong Transtek Medical Electronics (300562) revenue was CN¥235.76M. Earnings per share (EPS) for the quarter were CN¥0.11. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 3:44 AM Eastern Time

📈 Analyst Information

Based on the latest available analyst coverage, Guangdong Transtek Medical Electronics (300562) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 3:44 AM Eastern Time

Like other publicly traded stocks, Guangdong Transtek Medical Electronics (300562) shares are bought and sold on stock exchanges such as SZSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Guangdong Transtek Medical Electronics (300562) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add 300562 to your watchlist.

Guangdong Transtek Medical Electronics trades under the ticker symbol 300562 on the SZSE stock exchange. The ticker 300562 is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Guangdong Transtek Medical Electronics (300562) employs approximately 1,182 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: January 1, 2026 at 12:06 AM Eastern Time

Guangdong Transtek Medical Electronics (300562) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Guangdong Transtek Medical Electronics (300562) stock peers based on overlapping products, services, and competitive dynamics:TaiDoc Technology (4736)Andon Health (002432)Zylox-Tonbridge Medical Technology (2190)Beijing Bohui Innovation Biotechnology Group (300318)Shanghai Kinetic Medical (300326)Guangdong Biolight Meditech (300246)BMC Medical (301367)Shenzhen Lifotronic Technology (688389) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Guangdong Transtek Medical Electronics.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.